These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones. Higuchi RI, Arienti KL, López FJ, Mani NS, Mais DE, Caferro TR, Long YO, Jones TK, Edwards JP, Zhi L, Schrader WT, Negro-Vilar A, Marschke KB. J Med Chem; 2007 May 17; 50(10):2486-96. PubMed ID: 17439112 [Abstract] [Full Text] [Related]
5. Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators. Unwalla R, Mousseau JJ, Fadeyi OO, Choi C, Parris K, Hu B, Kenney T, Chippari S, McNally C, Vishwanathan K, Kilbourne E, Thompson C, Nagpal S, Wrobel J, Yudt M, Morris CA, Powell D, Gilbert AM, Chekler ELP. J Med Chem; 2017 Jul 27; 60(14):6451-6457. PubMed ID: 28696695 [Abstract] [Full Text] [Related]
7. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I. Aikawa K, Miyawaki T, Hitaka T, Imai YN, Hara T, Miyazaki J, Yamaoka M, Kusaka M, Kanzaki N, Tasaka A, Shiraishi M, Yamamoto S. Bioorg Med Chem; 2015 May 15; 23(10):2568-78. PubMed ID: 25862209 [Abstract] [Full Text] [Related]
16. Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators. Marhefka CA, Gao W, Chung K, Kim J, He Y, Yin D, Bohl C, Dalton JT, Miller DD. J Med Chem; 2004 Feb 12; 47(4):993-8. PubMed ID: 14761201 [Abstract] [Full Text] [Related]
17. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure. Fragkaki AG, Angelis YS, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulos C. Steroids; 2009 Feb 12; 74(2):172-97. PubMed ID: 19028512 [Abstract] [Full Text] [Related]
18. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators. Martinborough E, Shen Y, Oeveren Av, Long YO, Lau TL, Marschke KB, Chang WY, López FJ, Vajda EG, Rix PJ, Viveros OH, Negro-Vilar A, Zhi L. J Med Chem; 2007 Oct 18; 50(21):5049-52. PubMed ID: 17887661 [Abstract] [Full Text] [Related]
19. Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity. Long YO, Higuchi RI, Caferro TR, Lau TL, Wu M, Cummings ML, Martinborough EA, Marschke KB, Chang WY, López FJ, Karanewsky DS, Zhi L. Bioorg Med Chem Lett; 2008 May 01; 18(9):2967-71. PubMed ID: 18400499 [Abstract] [Full Text] [Related]
20. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators. Piatnitski Chekler EL, Unwalla R, Khan TA, Tangirala RS, Johnson M, St Andre M, Anderson JT, Kenney T, Chiparri S, McNally C, Kilbourne E, Thompson C, Nagpal S, Weber G, Schelling S, Owens J, Morris CA, Powell D, Verhoest PR, Gilbert AM. J Med Chem; 2014 Mar 27; 57(6):2462-71. PubMed ID: 24527807 [Abstract] [Full Text] [Related] Page: [Next] [New Search]